EMERGENT BIOSOLUTIONS INC revenue breakdown overview

EMERGENT BIOSOLUTIONS INC revenue for the last year amounted to 1.01 B EUR, the most of which — 492.46 M EUR — came from its highest performing source at the moment, Medical Countermeasures Products, the year earlier bringing 405.17 M EUR. The greatest contribution to the revenue figure was made by United States — last year it brought EMERGENT BIOSOLUTIONS INC 794.61 M EUR, and the year before that — 550.13 M EUR.